• Nenhum resultado encontrado

Int. braz j urol. vol.38 número6

N/A
N/A
Protected

Academic year: 2018

Share "Int. braz j urol. vol.38 número6"

Copied!
11
0
0

Texto

Loading

Imagem

Figure 1 - Trial selection fl ow.
Table 1 - Characteristics of Excluded Studies.
Table 2 - Characteristics of Included Studies.
Figure 5 - Adverse events (grade > 3) of patients treated with Sipuleucel-T versus Placebo.to 2.66), asthenia (RR = 1.49; CI 95% = 0.30 to 7.31), nausea (RR = 2.03; CI 95% = 0.23 to 18.10), anemia (RR = 0.78; CI 95% = 0.31 to 1.92) and vomiting (RR = 1.

Referências

Documentos relacionados

Even though the male Hispanic population residing in the US described in our study is not directly comparable to the Puerto Rican male population living in PR, racial/ethnic

Lopes A, Bezerra AL, Pinto CA, Serrano SV, de MellO CA, Villa LL: p53 as a new prognostic factor for lymph node metastasis in penile carcinoma: analysis of 82 patients treated

The fact that microscopic focal testicu- lar infi ltration was confi rmed in only 1 of the 32 testicles in our sample, even in the presence of clinically apparent scrotal

Smith MJ, Akhtar NH, Tagawa ST: The current role of androgen deprivation in patients undergoing dose-escalated external beam radiation therapy for clinically localized

Re: A review of continuous vs intermittent androgen deprivation therapy: Redefining the gold standard in the treatment of advanced prostate cancer.. Myths, facts and new data on

After 12 months of androgen deprivation therapy, elderly males with metastatic prostate cancer exhibit declines in lean body mass and lipid oxidation, together with an increase in

No entanto, o número de ECAC incluídos foi relativamente baixo, sendo que a maioria apresentava baixa qualidade relativamente ao seu desenho de estudo e à sua metodologia

Dual add-on therapy in type 2 diabetes poorly controlled with metfor- min monotherapy: a randomized double-blind trial of saxagliptin plus dapagliflozin addition versus